verapamil has been researched along with pak 104p in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akiyama, SI; Chen, ZS; Chuman, Y; Furukawa, T; Haraguchi, M; Seto, K; Shudo, N; Sumizawa, T; Tani, A | 1 |
| Dagger, F; Essodaïgui, M; Frézard, F; Garnier-Suillerot, A; Moreira, ES | 1 |
| Garnier-Suillerot, A; Loechariyakul, P; Saengkhae, C; Salerno, M | 1 |
3 other study(ies) available for verapamil and pak 104p
| Article | Year |
|---|---|
Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
Topics: Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Benzylisoquinolines; Cyclic P-Oxides; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Humans; Leukotriene C4; Multidrug Resistance-Associated Proteins; Nicotinic Acids; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vincristine | 1997 |
Energy-dependent efflux from Leishmania promastigotes of substrates of the mammalian multidrug resistance pumps.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; Biological Transport; Cyclic P-Oxides; Doxorubicin; Drug Resistance, Multiple; Energy Metabolism; Fluoresceins; Fluorescent Dyes; Leishmania; Nicotinic Acids; Phenothiazines; Tumor Cells, Cultured; Verapamil | 1999 |
Relation between the ability of some compounds to modulate the MRP1-mediated efflux of glutathione and to inhibit the MRPl-mediated efflux of daunorubicin.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cyclic P-Oxides; Daunorubicin; Glutathione; Humans; Nicotinic Acids; Propionates; Quinolines; Tumor Cells, Cultured; Verapamil | 2004 |